Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

被引：0
|
作者：
G E Konecny
R Glas
J Dering
K Manivong
J Qi
R S Finn
G R Yang
K-L Hong
C Ginther
B Winterhoff
G Gao
J Brugge
D J Slamon
机构：
[1] David Geffen School of Medicine,Division of Hematology
[2] University of California Los Angeles,Oncology, Department of Medicine
[3] Mayo Clinic,Division of Gynecologic Surgery, Department of Obstetrics and Gynecology
[4] Harvard Medical School,Department of Cell Biology
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
Src; Eph2A; FAK; uPA; dasatinib; ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1708
页数：9
相关论文
共 50 条
  • [21] Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
    Bahman, Fatemah
    Pittala, Valeria
    Haider, Mohamed
    Greish, Khaled
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [22] Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
    Benoît Thibault
    Bertrand Jean-Claude
    Journal of Ovarian Research, 10
  • [23] Trabectedin as a single agent and in combination with pegylated liposomal doxorubicin - activity against ovarian cancer cells
    Marczak, Agnieszka
    Denel, Marta
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (03): : 149 - 152
  • [24] Deciphering Biophysical Modulation in Ovarian Cancer Cells
    Sarwar, Makhdoom
    Sykes, Peter H.
    Chitcholtan, Kenny
    Evans, John J.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (02) : 375 - 386
  • [25] In vitro activity of human chorionic gonadotropin (hCG) -: Doxorubicin conjugates against ovarian cancer cells
    Beck, EP
    Vincenti, D
    Licht, P
    Berkholz, A
    Jäger, W
    Lang, N
    Merkle, E
    ANTICANCER RESEARCH, 2000, 20 (5A) : 3001 - 3006
  • [26] Dasatinib plus Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
    Thibault, Benoit
    Jean-Claude, Bertrand
    JOURNAL OF OVARIAN RESEARCH, 2017, 10
  • [27] Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells
    Min Shi
    Bingxiang Lou
    Jun Ji
    Hailong Shi
    Chenfei Zhou
    Yingyan Yu
    Bingya Liu
    Zhenggang Zhu
    Jun Zhang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 35 - 44
  • [28] Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells
    Shi, Min
    Lou, Bingxiang
    Ji, Jun
    Shi, Hailong
    Zhou, Chenfei
    Yu, Yingyan
    Liu, Bingya
    Zhu, Zhenggang
    Zhang, Jun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 35 - 44
  • [29] Expression and activity analysis of a new fusion protein targeting ovarian cancer cells
    Su, Manman
    Chang, Weiqin
    Wang, Dingding
    Cui, Manhua
    Lin, Yang
    Wu, Shuying
    Xu, Tianmin
    ONCOLOGY REPORTS, 2015, 34 (03) : 1337 - 1344
  • [30] The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
    Lapinska, Karolina
    Housman, Genevieve
    Byler, Shannon
    Heerboth, Sarah
    Willbanks, Amber
    Oza, Anuja
    Sarkar, Sibaji
    ANTICANCER RESEARCH, 2016, 36 (11) : 5731 - 5742
12345